Imperial College London

DrRichardSzydlo

Faculty of MedicineDepartment of Immunology and Inflammation

Medical Statistician
 
 
 
//

Contact

 

+44 (0)20 3313 2170r.szydlo Website

 
 
//

Location

 

4N7Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Claudiani:2021:10.1111/bjh.17286,
author = {Claudiani, S and Apperley, JF and Szydlo, R and Khan, A and Nesr, G and Hayden, C and J, Innes A and Dominy, K and Foskett, P and Foroni, L and Khorashad, J and Milojkovic, D},
doi = {10.1111/bjh.17286},
journal = {BRITISH JOURNAL OF HAEMATOLOGY},
pages = {346--355},
title = {TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia},
url = {http://dx.doi.org/10.1111/bjh.17286},
volume = {193},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Claudiani,S
AU - Apperley,JF
AU - Szydlo,R
AU - Khan,A
AU - Nesr,G
AU - Hayden,C
AU - J,Innes A
AU - Dominy,K
AU - Foskett,P
AU - Foroni,L
AU - Khorashad,J
AU - Milojkovic,D
DO - 10.1111/bjh.17286
EP - 355
PY - 2021///
SN - 0007-1048
SP - 346
TI - TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia
T2 - BRITISH JOURNAL OF HAEMATOLOGY
UR - http://dx.doi.org/10.1111/bjh.17286
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000601247300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 193
ER -